The future of immunosuppression: a personal view.
Morris
R E
RE
Novartis Institutes of BioMedical Research, Basel, Switzerland.
D000818:Animals; D006084:Graft Rejection / Q000276:immunology* / Q000517:prevention & control; D006801:Humans; D007165:Immunosuppression Therapy / Q000639:trends*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*
D007166:Immunosuppressive Agents